Prediction of Treatment Efficacy and Telaprevir-Resistant Variants after Triple Therapy in Patients Infected with Hepatitis C Virus Genotype 1

Article Usage Stats Services JCM Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue JCM About JCM Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Com...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of Clinical Microbiology 2013-09, Vol.51 (9), p.2862-2868
Hauptverfasser:	Akuta, Norio, Suzuki, Fumitaka, Fukushima, Taito, Kawamura, Yusuke, Sezaki, Hitomi, Suzuki, Yoshiyuki, Hosaka, Tetsuya, Kobayashi, Masahiro, Hara, Tasuku, Kobayashi, Mariko, Saitoh, Satoshi, Arase, Yasuji, Ikeda, Kenji, Kumada, Hiromitsu
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Antiviral Agents - therapeutic use Asian Continental Ancestry Group Drug Therapy, Combination - methods Female Genotype Hepacivirus - classification Hepacivirus - genetics Hepacivirus - isolation & purification Hepatitis C virus Hepatitis C, Chronic - drug therapy Hepatitis C, Chronic - virology High-Throughput Nucleotide Sequencing Humans Interferon-alpha - therapeutic use Male Middle Aged Oligopeptides - therapeutic use Prognosis Ribavirin - therapeutic use RNA, Viral - genetics Treatment Outcome Virology Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!